Asociación Española de PediatríaRecomendaciones para la prevención de la infección por virus respiratorio sincitialRecommendations for the prevention of respiratory syncytial virus infections
Bibliografía (70)
- et al.
Sobre recomendaciones, protocolos y guías clínicas
An Esp Pediatr
(2001) - et al.
Recomendaciones para la prevención de la infección por virus respiratorio sincitial
An Esp Pediatr
(2000) - et al.
Recomendaciones para la prevención de la infección por virus respiratorio sincitial: Revisión
An Esp Pediatr
(2002) - et al.
Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women
Vaccine
(2003) - et al.
Infecciones virales de vías respiratorias inferiores en lactantes hospitalizados: etiología, características clínicas y factores de riesgo
An Esp Pediatr
(2001) Respiratory sycytial virus infection
Lancet
(1999)- et al.
Effect of prematurity on respiratory syncytial virus hospital resource use and outcomes
J Pediatr
(2003) Morbidity and mortality after RSV-associated hospitalizations among premature Canadian infants
J Pediatr
(2003)Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease
J Pediatr
(2003)Review of epidemiology and clinical risk factors for severe respiratory syncytial virus infection
J Pediatr
(2003)
Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years
Lancet
(1999)
Asma y virus respiratorio sincitial ¿Mito o realidad?
An Esp Pediatr
(2002)
Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease
J Pediatr
(2003)
Committee on Infectious Diseases and Committee on Fetus and Newborn. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections
Pediatrics
(2003)
Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants
Pediatrics
(1998)
Respiratory Syncytial virus epidemiology in Belgium in 1998, 1999 y 2000
J Perinat Med
(2001)
Respiratory syncytial virus
Bronchiolitis
En: New Vaccine Development Establishing Priorities
(1988)
Bronquiolitis. Revisión de 153 casos y estudio comparative del tratamiento con ribavirina
An Esp Pediatr
(1997)
Hospitalization for respiratory syncytial virus in the paediatric population in Spain
Epidemiol Infect
(2003)
Advances in the treatment and prevention of severe viral bronchiolitis
Pediatric Annals
(2005)
Hospital admission of high risk infants for respiratory syncytial virus infection: Implications for palivizumab prophylaxis
Arch Dis Child Fetal Neonatal
(2005)
Rehospitalization for respiratory syncytial virus infection in infants with extremely low gestational age or birthweight in Denmark
Acta Paediatr
(2003)
Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants
Pediatr Infect Dis J
(2003)
Prevalence of respiratory syncytial virus infection in Italian infants hospitalized for acute lower respiratory tract infections,and association between respiratory syncytial virus infectionrisk factors and disease severity
Pediatr Pulmonol
(2002)
Rehospitalization because of respiratory syncytial virus infection in premature infants younger than 33 weeks of gestation: A prospective study
Pediatr Infect Dis J
(2000)
Hospitalization rates for respiratory syncytial virus infection in premature infants younger born during two consecutive seasons
Pediatr Infect Dis J
(2001)
Comparación con el Impact-RSV Study Group
An Esp Pediatr
(2000)
Effectiveness of palivizumab; evaluation of outcomes from the 1998 to 1999 respiratory syncytial virus season
Pediatr Infect Dis J
(2000)
Phase I evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants
JID
(2001)
Selected populations at increased risk from respiratory syncytial virus infection
Pediatr Infect Dis J
(2003)
Prediction of duration of hospitalization in respiratory syncytial virus infection
Pediatric Pulmonol
(2002)
Health Care utilisation of infants with chronic lung disease, related to hospitalisation for RSV infection
Arch Dis Child
(2001)
Cited by (0)
Copyright © 2005 Asociación Española de Pediatría. Published by Elsevier España S.L. All rights reserved.